In addition, we find that ALS-BCMA responses in individuals vaccinated with ETVAX plus the adjuvant double mutant heat-labile toxin (dmLT) are significantly higher than in subjects given ETVAX only. The gene discussed is TNFRSF17; the disease is amyotrophic lateral sclerosis.